about
Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agentsInsights into the antimicrobial properties of hepcidins: advantages and drawbacks as potential therapeutic agentsBiochemical properties and possible roles of ectophosphatase activities in fungiTranscriptional Control of Drug Resistance, Virulence and Immune System Evasion in Pathogenic Fungi: A Cross-Species ComparisonAre the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their AccuracySaccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticumIdentification and analysis of cation channel homologues in human pathogenic fungiAntifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profilePurpurin triggers caspase-independent apoptosis in Candida dubliniensis biofilmsA role for FACT in repopulation of nucleosomes at inducible genesThe widely used ATB FUNGUS 3 automated readings in China and its misleading high MICs of Candida spp. to azoles: challenges for developing countries' clinical microbiology labsAn automated high-throughput cell-based multiplexed flow cytometry assay to identify novel compounds to target Candida albicans virulence-related proteinsCharacterization of Cell Wall Proteins in Saccharomyces cerevisiae Clinical Isolates Elucidates Hsp150p in VirulenceThe airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic managementActivity of crude extracts from Brazilian cerrado plants against clinically relevant Candida speciesFirst Two Cases of Fungal Infections Associated with Multi-drug Resistant Yeast, Fereydounia khargensisEfficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis.A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature.Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles.Dectin-1 Controls TLR9 Trafficking to Phagosomes Containing β-1,3 GlucanReliable differentiation of Meyerozyma guilliermondii from Meyerozyma caribbica by internal transcribed spacer restriction fingerprinting.Candida mesorugosa sp. nov., a novel yeast species similar to Candida rugosa, isolated from a tertiary hospital in Brazil.Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain.Bloodstream infections by Malassezia and Candida species in critical care patients.Can oral infection be a risk factor for Alzheimer's disease?Emerging organisms in a tertiary healthcare set up.Molecular evidence on the occurrence of co-infection with Pichia guilliermondii and Wuchereria bancrofti in two filarial endemic districts of IndiaMolecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system.Diversity, in-vitro virulence traits and antifungal susceptibility pattern of gastrointestinal yeast flora of healthy poultry, Gallus gallus domesticusA pre-therapeutic coating for medical devices that prevents the attachment of Candida albicans.A Chitin-binding Protein Purified from Moringa oleifera Seeds Presents Anticandidal Activity by Increasing Cell Membrane Permeability and Reactive Oxygen Species ProductionCandida infections and their prevention.Molecular identification of uncommon clinical yeast species in IranEvaluation of repetitive sequence PCR and PCR-mass spectrometry for the identification of clinically relevant Candida species.Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates.Wild-type Drosophila melanogaster as a model host to analyze nitrogen source dependent virulence of Candida albicans.Are subinhibitory concentrations of antibiotics the only culprit of antibiotic resistance?The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.The Effect of the acetone extract of Arctotis arctotoides (Asteraceae) on the growth and ultrastructure of some opportunistic fungi associated with HIV/AIDS.Photodynamic inactivation of biofilms formed by Candida spp., Trichosporon mucoides, and Kodamaea ohmeri by cationic nanoemulsion of zinc 2,9,16,23-tetrakis(phenylthio)-29H, 31H-phthalocyanine (ZnPc).
P2860
Q26863344-A50A9180-F079-498C-B28D-3CA72794A676Q26991996-4831EB48-05D5-4C93-8BA8-F8498ECB5F13Q27023256-EF404E8B-CA65-43C5-A1B6-DBFCBCEC3278Q28079641-1D3E3B1C-61C8-412F-BD79-67ED24EE8069Q28084765-A8498476-F694-4672-A5B9-ADBB7311915AQ28236940-BB47989B-FFDE-41BD-91BD-ADFB84115420Q28481844-A01D3FA6-7856-41F4-B415-7CD5707A7D88Q28489096-E573C260-9766-41DB-9912-3314BFA40F20Q28537918-C7DB4E77-1161-409E-B6B9-E2EB12207AA5Q28538271-D5C604DA-66EF-417D-B9D1-11C5525FB1C0Q28542429-D1403EB1-445B-4900-B941-4235526911B8Q28544418-BA053576-EBFD-49D6-8614-65DF0EE43D2EQ28547230-ED95F9C1-B098-47FF-864D-BA5259E55D35Q28730299-C2B72FC3-03AE-4C33-8D12-B29F1803CE41Q28830609-429DF9DD-3CDB-422A-B7D1-282B14542D9FQ28831031-8FF58CCD-C66D-42DC-8277-31D5C7A36D45Q30240770-40154709-FCF9-40F1-B8AC-3AE9E0BB0DFCQ30251621-D52C2E1D-8714-4046-8101-D0062FBC0215Q30300387-A19C3507-3204-429D-B65B-89B379B25932Q30362279-3AAB784B-3C03-4B5A-A506-4874D9DE5C9DQ30392109-D86D6E7F-84C5-44AA-97D8-1D398EEEA61AQ30559661-648B3176-5B0B-436C-B6EB-CAD0C3896112Q31119810-4F129709-F768-4A1E-88F9-F0409915C46EQ31151975-661D091C-37A4-468E-AB30-23EC0DDB38B7Q33361553-EAF4A090-53F8-484F-8933-102D8EDD6AEDQ33595380-49EDF120-D8AF-44D5-8321-2F4725AB70A0Q33615436-157E2F08-C51B-475C-A48C-A1921A235776Q33680814-890F2CD5-EA46-47D6-9645-A1A3E2C097A7Q33692141-004E7D54-30CC-431F-8A9E-07FB297F5D6EQ33709290-E54C5C87-B810-4581-8679-06EBD3767D02Q33766309-62CBCD83-D770-4248-AC48-5977E216C733Q33775256-930E71B7-25FD-4912-A11B-922A57533741Q33851352-4F669895-AE65-4ADC-BEAC-6D033C6BEBF3Q34000455-78013076-7EAA-4936-882C-2EC81ADA43F5Q34067285-D7E2438C-3E1A-4E63-8113-3C2CBF8D1576Q34081541-AB0F01FA-38A7-4326-9C32-F04F29A158F1Q34084784-7818C6B1-A936-461E-8B4B-F08D80195BFCQ34112865-08C446FE-0B46-45B8-BA39-BEA9CA52AEA3Q34137147-A52ED37D-70E2-4B18-AE06-F2FE5E48FD96Q34141242-9AF1375A-9A51-4CFC-BE73-66F32545ED60
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging opportunistic yeast infections.
@en
Emerging opportunistic yeast infections.
@nl
type
label
Emerging opportunistic yeast infections.
@en
Emerging opportunistic yeast infections.
@nl
prefLabel
Emerging opportunistic yeast infections.
@en
Emerging opportunistic yeast infections.
@nl
P2093
P1476
Emerging opportunistic yeast infections.
@en
P2093
José A Díaz
Marisa H Miceli
Samuel A Lee
P304
P356
10.1016/S1473-3099(10)70218-8
P577
2011-02-01T00:00:00Z